It is the European Medicines Agency (EMA) that assesses whether a vaccine can be marketed. “And all vaccines will be properly assessed before being authorized,” said Commission President von der Leyen.
Two vaccines, that of Pfizer / BioNTech and Moderna, may be licensed this year. “If all goes well without any problems, EMA could grant conditional marketing authorization in the second half of December,” von der Leyen was told by the European Medicines Agency, which consults daily with the US counterpart FDA.
–
